American International Group, Inc. Vaxcyte, Inc. Transaction History

American International Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$59.79 - $81.05 $339,965 - $460,850	5,686 Added 12.19%	52,313 $3.57 Million
Q4 2023 Feb 13, 2024	SELL	$45.35 - $63.41 $8,525 - $11,921	-188 Reduced 0.4%	46,627 $2.93 Million
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $117,898 - $136,095	2,563 Added 5.79%	46,815 $2.39 Million
Q2 2023 Aug 04, 2023	BUY	$34.66 - $54.07 $334,087 - $521,180	9,639 Added 27.85%	44,252 $2.21 Million
Q1 2023 May 12, 2023	BUY	$36.27 - $47.2 $24,990 - $32,520	689 Added 2.03%	34,613 $1.3 Million
Q4 2022 Feb 10, 2023	BUY	$20.58 - $47.95 $171,904 - $400,526	8,353 Added 32.67%	33,924 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $19,499 - $25,648	899 Added 3.64%	25,571 $614,000
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $61,915 - $93,083	3,502 Added 16.54%	24,672 $537,000
Q1 2022 May 13, 2022	SELL	$17.46 - $26.36 $5,185 - $7,828	-297 Reduced 1.38%	21,170 $511,000
Q4 2021 Feb 11, 2022	SELL	$19.32 - $26.45 $12,422 - $17,007	-643 Reduced 2.91%	21,467 $511,000
Q3 2021 Nov 12, 2021	SELL	$20.26 - $26.97 $3,282 - $4,369	-162 Reduced 0.73%	22,110 $561,000
Q2 2021 Aug 13, 2021	BUY	$16.45 - $24.06 $88,616 - $129,611	5,387 Added 31.9%	22,272 $501,000
Q1 2021 May 07, 2021	BUY	$18.66 - $29.16 $117,539 - $183,678	6,299 Added 59.5%	16,885 $333,000
Q4 2020 Feb 12, 2021	SELL	$26.57 - $51.74 $8,050 - $15,677	-303 Reduced 2.78%	10,586 $281,000
Q3 2020 Nov 04, 2020	BUY	$26.5 - $55.4 $288,558 - $603,250	10,889 New	10,889 $538,000

349

130M

539K

253K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.73B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.